Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2003
11/20/2003US20030216462 Anticancer agents; psoriasis
11/20/2003US20030216452 Method of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substitute indolealkanoic acids
11/20/2003US20030216450 Inhibitors of dipeptidyl peptidase IV
11/20/2003US20030216443 Antidiabetic agents; using mixture of enzyme inhibitors
11/20/2003US20030216432 Non-insulin sensitive diabetes; anticancer agents ; therapy, medical diagnosis
11/20/2003US20030216401 Anti-obesity 1, 2, 3, 4, 10, 10a-hexahydropyrazino[1, 2-a] indoles
11/20/2003US20030216399 A dipeptide containing bi or tri-heterocylic ring with nitrogen atom which forms amide with carbonyl group of dipeptide chain; useful for treating osteoporosis, congestive heart failure and accelerates wound healing
11/20/2003US20030216391 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
11/20/2003US20030216390 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
11/20/2003US20030216383 Compounds useful as reversible inhibitors of cysteine proteases
11/20/2003US20030216382 Useful for the treatment and/or prophylaxis of diseases associated with dipeptidyl peptidase, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance
11/20/2003US20030216381 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer
11/20/2003US20030216375 Sulfonamide substituted diphenyl thiourea compounds; use thereof in treating IL-8, GRO alpha, GRO beta, GRO gamma, NAP-2, and ENA-78 mediated diseases
11/20/2003US20030216368 Hormone replacement therapy
11/20/2003US20030216367 In perimenopausal, menopausal, and postmenopausal women through the sequential administration of combinations of conjugated estrogens and trimegestone
11/20/2003US20030216357 Compositions for improving lipid content in the blood
11/20/2003US20030216356 Cause the selective destruction of tumour vasculature; are used to inhibit and/or reverse, and/or alleviate symptoms of angiogenesis
11/20/2003US20030216333 Antisense modulation of glycogen synthase kinase3 alpha expression
11/20/2003US20030216330 Especially for methicillin or vancomycin resistant Staphylococcus aureus, vancomycin resistant Enterococci or glycopeptide-intermediate Staphylococcus aureus
11/20/2003US20030216328 Androgen derivatives and uses thereof
11/20/2003US20030216294 Synergistic effect of a sulfonylurea and/or non-sulfonylurea Kchannel blocker, and a phosphodiesterase 3 type inhibitor
11/20/2003US20030216290 Methods and compositions of treating and/or preventing diabetic retinopathy with pericyte apoptosis inhibitors
11/20/2003US20030215943 Antisense modulation of apolipoprotein B expression
11/20/2003US20030215829 Nuclear hormone receptors
11/20/2003US20030215823 Uses of galanin GALR2 receptors
11/20/2003US20030215787 Modulators of the CLC-7 chloride channel and methods for their identification and use in the treatment and prevention of osteoporosis and related disease states
11/20/2003US20030215562 Crystal structure, enzyme resistance, nonhydrolyzing, nonabsorption in the small intestine, and passes into the large intestine, fermentation by colonic microflora to maintain colonic health
11/20/2003US20030215561 Crystal structure, enzyme resistance, nonhydrolyzing, nonabsorption in the small intestine, and passes into the large intestine, fermentation by colonic microflora to maintain colonic health
11/20/2003US20030215534 Mixing psyllium seeds with basic solutions, then seperating the insoluble and soluble gels, disinfecting, and acidifying to form compressible polysaccharides used as dietary fiber
11/20/2003US20030215501 An oral formulation containing from about 10% to 90% of a gel-forming polysaccharide derived from psyllium seed husk (containing xylose and arabinose)and 10% to about 90% of a fast dissolving excipient
11/20/2003US20030215496 Solid carrier includes a hydrophililc surfactant and a drug
11/20/2003US20030215450 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
11/20/2003CA2492044A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
11/20/2003CA2485753A1 Benzimidazole derivatives
11/20/2003CA2485527A1 Substituted pyrroline kinase inhibitors
11/20/2003CA2485083A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003CA2484968A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003CA2484144A1 Eif-5a nucleic acids for inhibiting apoptosis
11/20/2003CA2482541A1 Use of valsartan or its metabolite to inhibit platelet aggregation
11/20/2003CA2480488A1 Novel diazabicyclic biaryl derivatives
11/19/2003EP1362919A1 Slowly digestible starch product
11/19/2003EP1362916A2 Human tumor necrosis factor delta and epsilon
11/19/2003EP1362911A1 Transgenic animal having drug metabolism enzyme gene and utilization thereof
11/19/2003EP1362869A1 Resistant starch prepared by isoamlase debranching of low amylose starch
11/19/2003EP1362855A1 Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
11/19/2003EP1362848A1 Process for the preparation of vitamin D derivatives
11/19/2003EP1362105A2 Anti-interferon-alpha antibodies
11/19/2003EP1362095A2 Post-partum mammalian placenta, its use and placental stem cells therefrom
11/19/2003EP1362061A2 Antibodies that bind both bcma and taci
11/19/2003EP1362047A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors
11/19/2003EP1362046A1 Substituted pyrimidinone derivatives as ligands of integrin receptors
11/19/2003EP1362045A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/19/2003EP1362031A1 Pharmaceutically active piperidine derivatives
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP1361892A1 Binding domain-immunoglobulin fusion proteins
11/19/2003EP1361870A2 A substance for use in a dietary supplement or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
11/19/2003EP1361867A1 Fibrate-statin combinations with reduced fed-fasted effects
11/19/2003EP1361864A2 Mucoadhesive pharmaceutical formulations
11/19/2003EP1240141B1 New modulators of dopamine neurotransmission
11/19/2003EP1179005B1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/19/2003EP1117628B1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
11/19/2003EP0914111B1 Prevention and treatment of cachexia and anorexia
11/19/2003EP0884052B1 Cartilage/bone inducing materials for reparation
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/19/2003EP0733066B1 Pretargeting methods and compounds
11/19/2003CN1457357A Products containing S G (b)-glucan
11/19/2003CN1457337A Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
11/19/2003CN1457255A Compositions of biochemical compounds involved in bioenergy metabolism of cells and method of use
11/19/2003CN1456669A Method for producing human insulin by transgene romaine lettuce, tomato and tobaco
11/19/2003CN1456660A Ginkgo juice extracting method, food and medicine therefrom
11/19/2003CN1456338A Medicine for treating diabets mellitus
11/19/2003CN1456337A Balsam pear products containing multiple hypoglycemic active composition and preparation thereof
11/19/2003CN1456332A Fast-effective stomachic kidney tonifying capsule and preparing method thereof
11/19/2003CN1456328A Schisandra fruit and black plum capsules for reducing sugar and fat in blood
11/19/2003CN1456320A Medicine for treating diabets mellitus
11/19/2003CN1456314A Hypoglycemic capsule
11/19/2003CN1456309A Antilipemic antiatherosclerosis medicine composition and preparing method, application thereof
11/19/2003CN1456306A Cattail pollen total extractive, preparation and preparing method thereof
11/19/2003CN1456283A Preparing method of antilipemic capsule for invigorating pulse-beat
11/19/2003CN1456259A Melbine preparing method
11/19/2003CN1456258A Preparation of Tangniaole against glycuresis
11/19/2003CN1456250A Antilipemic capsule preparing method
11/19/2003CN1456218A Medicine for curing diabets mellitus by natural plants
11/19/2003CN1456193A Natural sugar inhibiting elements
11/19/2003CN1456189A Healthy products for regulating blood fat and removing heat from throat
11/19/2003CN1456182A Fatty acid synthetase inhibitor, preparing method and application thereof
11/19/2003CN1456172A Healthy vitamin nutrient solution
11/19/2003CN1128224C Process for production of lipstation and tetraphydrolipstatin
11/19/2003CN1128223C Production process of compound L-amino acid calcium
11/19/2003CN1128144C Indane-1-alcohol compound, its preparation method and medical composition containing same
11/19/2003CN1128142C Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same
11/19/2003CN1127951C Application of rhein in treating insulin resistance
11/19/2003CN1127949C Composite coenzyme Q10 health nutriment
11/18/2003US6649755 Process for preparing acarbose with high purity
11/18/2003US6649641 Glucagon antagonists/inverse agonists
11/18/2003US6649640 Isoxazole compositions useful as inhibitors of ERK
11/18/2003US6649633 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
11/18/2003US6649628 Retinopathy, neuropathy and nephropathy treatment; antidiabetic agents
11/18/2003US6649627 N-Substituted with 1- (pyrid-2-yl)-piperidine-4-yl radical; gastrointestinal and psychological disorder treatment; antidiabetic tocolytic, and antidepressant agents; irritable bowel syndrome, glaucoma and dysmenorrhoea
11/18/2003US6649623 Administering tetrahydropiperidine derivative; antidiabetic agents; hyperlipemia treatment; hypotensive agents
1 ... 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 ... 1298